Published in New Horiz on May 01, 1998
The role of infection in acute pancreatitis. Gut (1999) 1.66
Fluconazole penetration into the pancreas. Antimicrob Agents Chemother (2000) 0.85
The impact of hospital-acquired infection on outcome in acute pancreatitis. Gastroenterology (2008) 0.83
Multi-drug-resistant Klebsiella pneumoniae pancreatitis: a new challenge in a serious surgical infection. Surg Infect (Larchmt) (2014) 0.82
Blood serum levels of proinflammatory cytokines in patients with different degrees of biliary pancreatitis. Can J Gastroenterol (2006) 0.81
Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet (2001) 5.75
Randomized clinical trial on the effect of coffee on postoperative ileus following elective colectomy. Br J Surg (2012) 4.01
Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg (2004) 3.90
Fewer adhesions induced by laparoscopic surgery? Surg Endosc (2004) 3.11
Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg (2001) 2.94
Use of accurate diagnostic criteria may increase incidence of stercoral perforation of the colon. Dis Colon Rectum (2000) 2.41
Incisional hernia rate 3 years after midline laparotomy. Br J Surg (2013) 2.37
Sulforaphane targets pancreatic tumour-initiating cells by NF-kappaB-induced antiapoptotic signalling. Gut (2008) 2.36
Randomized controlled multicentre study of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis. Br J Surg (1995) 2.36
Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer. Br J Cancer (2005) 2.32
Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance. Clin Cancer Res (2001) 2.24
The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer. J Clin Invest (1998) 2.22
Systematic review and meta-analysis of technique for closure of the pancreatic remnant after distal pancreatectomy. Br J Surg (2005) 2.18
Retroperitoneal endoscopic neurectomy for nerve entrapment after hernia repair. Br J Surg (1997) 2.12
Missed diaphragmatic injuries and their long-term sequelae. J Trauma (1998) 2.09
Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency. Digestion (2000) 2.09
The problem of the poor control arm in surgical randomized controlled trials. Br J Surg (2012) 2.08
Incidence, risk factors, and prevention of biliary tract injuries during laparoscopic cholecystectomy in Switzerland. World J Surg (2001) 2.07
Circulatory and respiratory complications of carbon dioxide insufflation. Dig Surg (2004) 2.06
Neuroimmune appendicitis. Lancet (1999) 2.05
Management of acute pancreatitis: from surgery to interventional intensive care. Gut (2005) 2.02
Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. EORTC Study Group on Quality of Life. Eur J Cancer (1999) 1.99
Carcinoid of the ampulla of Vater. Clinical characteristics and morphologic features. Cancer (1994) 1.97
Late mortality in patients with severe acute pancreatitis. Br J Surg (2001) 1.92
Systematic review and meta-analysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer. Br J Surg (2007) 1.92
High coincidence of Mirizzi syndrome and gallbladder carcinoma. Surgery (1997) 1.89
Effect of preoperative biliary drainage on surgical outcome after pancreatoduodenectomy. Am J Surg (2001) 1.87
Robot-assisted abdominal surgery. Br J Surg (2004) 1.85
VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma. Br J Cancer (2008) 1.84
Detection and localization of Mip-3alpha/LARC/Exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer. Int J Cancer (1999) 1.81
Robot-assisted versus conventional laparoscopic fundoplication: short-term outcome of a pilot randomized controlled trial. Surg Endosc (2007) 1.75
Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression. Clin Cancer Res (1997) 1.74
Role of serum carbohydrate antigen 19-9 and carcinoembryonic antigen in distinguishing between benign and invasive intraductal papillary mucinous neoplasm of the pancreas. Br J Surg (2010) 1.73
Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials. Br J Cancer (2009) 1.69
Heparanase expression in primary and metastatic pancreatic cancer. Cancer Res (2001) 1.67
The role of infection in acute pancreatitis. Gut (1999) 1.66
The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer. Oncogene (1999) 1.63
Microarray-based identification of differentially expressed growth- and metastasis-associated genes in pancreatic cancer. Cell Mol Life Sci (2003) 1.60
Laparoscopic restorative proctocolectomy. Br J Surg (2005) 1.60
KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases. Cancer Res (1996) 1.59
Clinical significance of liver ischaemia after pancreatic resection. Br J Surg (2011) 1.59
The suprapubic approach for laparoscopic appendectomy. Surg Endosc (2001) 1.56
Overexpression and activation of the tyrosine kinase Src in human pancreatic carcinoma. Biochem Biophys Res Commun (1998) 1.52
High prevalence of Mycobacterium avium subspecies paratuberculosis IS900 DNA in gut tissues from individuals with Crohn's disease. Gut (2005) 1.51
Endoscopic retroperitoneal neurectomy for chronic pain after groin surgery. Br J Surg (2009) 1.50
Randomized clinical trial of stapler versus clamp-crushing transection in elective liver resection. Br J Surg (2014) 1.50
Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas. Br J Surg (2008) 1.50
Immune cell infiltration and growth-associated protein 43 expression correlate with pain in chronic pancreatitis. Gastroenterology (1997) 1.49
Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma. Br J Cancer (1997) 1.47
Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders. Gut (2001) 1.46
C-reactive protein as early predictor for infectious postoperative complications in rectal surgery. Int J Colorectal Dis (2007) 1.45
Randomized clinical trial of pylorus-preserving duodenopancreatectomy versus classical Whipple resection-long term results. Br J Surg (2005) 1.42
Adjuvant therapy in pancreatic cancer: historical and current perspectives. Ann Oncol (2003) 1.42
Enhanced expression of the type II transforming growth factor-beta receptor is associated with decreased survival in human pancreatic cancer. Pancreas (1999) 1.41
Liver nodules resembling focal nodular hyperplasia after hepatic venous thrombosis. J Hepatol (2000) 1.40
Emergency liver transplantation after umbilical hernia repair: a case report. Transplant Proc (2009) 1.40
Preoperative tissue diagnosis for tumours of the pancreas. Br J Surg (2009) 1.39
[Complicated course of a laparoscopic cholecystectomy]. Chirurg (2015) 1.38
[Stenting in chronic pancreatitis--the mistakes and limitations]. Z Gastroenterol (2000) 1.38
Nerve growth factor expression correlates with perineural invasion and pain in human pancreatic cancer. J Clin Oncol (1999) 1.38
Syndecan-1 expression is up-regulated in pancreatic but not in other gastrointestinal cancers. Int J Cancer (2000) 1.37
Growth factors and their receptors in pancreatic cancer. Teratog Carcinog Mutagen (2001) 1.37
The anti-apoptotic protein BAG-3 is overexpressed in pancreatic cancer and induced by heat stress in pancreatic cancer cell lines. FEBS Lett (2001) 1.37
Bone morphogenetic protein 2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer in vivo. Gastroenterology (1999) 1.36
Nerve growth factor and its high-affinity receptor in chronic pancreatitis. Ann Surg (1999) 1.35
Connective tissue growth factor is a regulator for fibrosis in human chronic pancreatitis. Ann Surg (1999) 1.34
Id-1 and Id-2 are overexpressed in pancreatic cancer and in dysplastic lesions in chronic pancreatitis. Am J Pathol (1999) 1.33
Induction and expression of amphiregulin in human pancreatic cancer. Cancer Res (1994) 1.32
Duodenum-preserving head resection in chronic pancreatitis changes the natural course of the disease: a single-center 26-year experience. Ann Surg (1999) 1.32
Human pancreatic tissue concentration of bactericidal antibiotics. Gastroenterology (1992) 1.31
Pancreatic infection in severe pancreatitis: the role of fungus and multiresistant organisms. Arch Surg (2001) 1.31
Increased expression of erbB3 in colorectal cancer is associated with concomitant increase in the level of erbB2. Hum Pathol (1998) 1.30
Splanchnic microcirculatory changes during CO2 laparoscopy. J Am Coll Surg (1997) 1.27
Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreas. Eur J Cancer (2004) 1.27
Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma. Am J Surg (1999) 1.27
Systematic review and meta-analysis of the effect of portal triad clamping on outcome after hepatic resection. Br J Surg (2008) 1.27
Cytotoxic cells are activated in cellular infiltrates of alcoholic chronic pancreatitis. Gastroenterology (1997) 1.26
Induction of platelet-derived growth factor A and B chains and over-expression of their receptors in human pancreatic cancer. Int J Cancer (1995) 1.26
A randomised, double blind, multicentre trial of octreotide in moderate to severe acute pancreatitis. Gut (1999) 1.26
The role of laparoscopy in symptomatic Meckel's diverticulum. Surg Endosc (1999) 1.25
Randomized prospective trial of pylorus-preserving vs. Classic duodenopancreatectomy (Whipple procedure): initial clinical results. J Gastrointest Surg (2000) 1.25
[Antibiotic use in necrotizing pancreatitis. Results of a controlled study]. Dtsch Med Wochenschr (1997) 1.24
Acute gallstone pancreatitis: timing of laparoscopic cholecystectomy in mild and severe disease. Surg Endosc (1999) 1.24
Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-D-glucose positron emission tomography. Gut (1995) 1.23
Coexpression of the c-met proto-oncogene and hepatocyte growth factor in human pancreatic cancer. Cancer Res (1994) 1.23
Reduced susceptibility of mice overexpressing transforming growth factor alpha to dextran sodium sulphate induced colitis. Gut (1998) 1.21
Vanilloids in pancreatic cancer: potential for chemotherapy and pain management. Gut (2005) 1.20
Mice harboring a defective epidermal growth factor receptor (waved-2) have an increased susceptibility to acute dextran sulfate-induced colitis. Scand J Gastroenterol (2000) 1.19
Randomized clinical trial of the influence of local water-filtered infrared A irradiation on wound healing after abdominal surgery. Br J Surg (2006) 1.19
Enhanced erbB-3 expression in human pancreatic cancer correlates with tumor progression. Clin Cancer Res (1995) 1.19
Pancreatic cancer: the potential clinical relevance of alterations in growth factors and their receptors. J Mol Med (Berl) (1996) 1.18
Fast track--different implications in pancreatic surgery. J Gastrointest Surg (2007) 1.16
Identification of disease-specific genes in chronic pancreatitis using DNA array technology. Ann Surg (2001) 1.16
Laparoscopic treatment of large paraesophageal hernia with totally intrathoracic stomach. J Am Coll Surg (1998) 1.15
Randomized clinical trial of a modified Seldinger technique for open central venous cannulation for implantable access devices. Br J Surg (2009) 1.15
Biliary cystadenocarcinoma of the liver: the need for complete resection. Eur J Cancer (1998) 1.14
Osteopontin influences the invasiveness of pancreatic cancer cells and is increased in neoplastic and inflammatory conditions. Cancer Biol Ther (2005) 1.14
Over-expression of ICAM-1, VCAM-1 and ELAM-1 might influence tumor progression in colorectal cancer. Int J Cancer (1998) 1.13
Increased expression of keratinocyte growth factor in human pancreatic cancer. Biochem Biophys Res Commun (1995) 1.13
bax, but not bcl-2, influences the prognosis of human pancreatic cancer. Gut (1998) 1.12